# Sono Tek Corp: overview SOTK · Nasdaq · CIK 806172 · [Industrials](/sectors/industrials.md) · fiscal year ends Feb 28 Pages: [Overview](/companies/sotk.md) · [Financials](/companies/sotk/financials.md) · [Filings](/companies/sotk/filings.md) · [Insiders](/companies/sotk/insiders.md) Latest reported revenue: [$5.2m](/filings/0001171520-26-000305.md) for Q2 FY2027, three months to 2026-08-31, from the 10-Q filed Oct 14, 2026 (XBRL us-gaap:Revenues, accession 0001171520-26-000305). ## Last eight quarters | Line item | Unit | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [5,191](/filings/0001171520-26-000004.md) | [5,121 d](/filings/0001171520-26-000113.md) | [5,133](/filings/0001171520-26-000167.md) | [5,163](/filings/0001171520-26-000305.md) | [5,004](/filings/0001171520-26-000004.md) | [5,609 d](/filings/0001171520-26-000113.md) | [5,661](/filings/0001171520-26-000167.md) | [5,232](/filings/0001171520-26-000305.md) | | Gross margin | % | [45.1%](/filings/0001171520-26-000004.md) | [47.4% d](/filings/0001171520-26-000113.md) | [51.9%](/filings/0001171520-26-000167.md) | [50.2%](/filings/0001171520-26-000305.md) | [50.2%](/filings/0001171520-26-000004.md) | [49.8% d](/filings/0001171520-26-000113.md) | [56.8%](/filings/0001171520-26-000167.md) | [52.9%](/filings/0001171520-26-000305.md) | | Operating margin | % | [3.8%](/filings/0001171520-26-000004.md) | [5.6% d](/filings/0001171520-26-000113.md) | [9.4%](/filings/0001171520-26-000167.md) | [8.2%](/filings/0001171520-26-000305.md) | [6.4%](/filings/0001171520-26-000004.md) | [10.7% d](/filings/0001171520-26-000113.md) | [15.8%](/filings/0001171520-26-000167.md) | [7.3%](/filings/0001171520-26-000305.md) | | Net margin | % | [5.3%](/filings/0001171520-26-000004.md) | [6.4% d](/filings/0001171520-26-000113.md) | [9.4%](/filings/0001171520-26-000167.md) | [8.2%](/filings/0001171520-26-000305.md) | [6.8%](/filings/0001171520-26-000004.md) | [9.9% d](/filings/0001171520-26-000113.md) | [13.1%](/filings/0001171520-26-000167.md) | [7.0%](/filings/0001171520-26-000305.md) | | Diluted EPS | $ per share | [0.02](/filings/0001171520-26-000004.md) | not reported | [0.03](/filings/0001171520-26-000167.md) | [0.03](/filings/0001171520-26-000305.md) | [0.02](/filings/0001171520-26-000004.md) | not reported | [0.05](/filings/0001171520-26-000167.md) | [0.02](/filings/0001171520-26-000305.md) | | Free cash flow | $k | [1,077 d](/filings/0001171520-26-000004.md) | [(740) d](/filings/0001171520-26-000113.md) | [(975)](/filings/0001171520-26-000167.md) | [(237) d](/filings/0001171520-26-000305.md) | [1,141 d](/filings/0001171520-26-000004.md) | [3,092 d](/filings/0001171520-26-000113.md) | [1,859](/filings/0001171520-26-000167.md) | [1,141 d](/filings/0001171520-26-000305.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-02-28) | FY2023 (2023-02-28) | FY2024 (2024-02-29) | FY2025 (2025-02-28) | FY2026 (2026-02-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [17.1](/filings/0001171520-23-000181.md) | [15.1](/filings/0001171520-24-000208.md) | [19.7](/filings/0001171520-25-000195.md) | [20.5](/filings/0001171520-26-000113.md) | [20.9](/filings/0001171520-26-000113.md) | | Gross margin | % | [50.3%](/filings/0001171520-23-000181.md) | [50.8%](/filings/0001171520-24-000208.md) | [50.0%](/filings/0001171520-25-000195.md) | [47.5%](/filings/0001171520-26-000113.md) | [50.5%](/filings/0001171520-26-000113.md) | | Operating margin | % | [11.0%](/filings/0001171520-23-000181.md) | [4.5%](/filings/0001171520-24-000208.md) | [6.0%](/filings/0001171520-25-000195.md) | [4.9%](/filings/0001171520-26-000113.md) | [8.7%](/filings/0001171520-26-000113.md) | | Net margin | % | [14.8%](/filings/0001171520-23-000181.md) | [4.2%](/filings/0001171520-24-000208.md) | [7.3%](/filings/0001171520-25-000195.md) | [6.2%](/filings/0001171520-26-000113.md) | [8.6%](/filings/0001171520-26-000113.md) | | Diluted EPS | $ per share | [0.16](/filings/0001171520-23-000181.md) | [0.04](/filings/0001171520-24-000208.md) | [0.09](/filings/0001171520-25-000195.md) | [0.08](/filings/0001171520-26-000113.md) | [0.11](/filings/0001171520-26-000113.md) | | Free cash flow | $m | [2.0](/filings/0001171520-23-000181.md) | [0.8](/filings/0001171520-24-000208.md) | [0.4](/filings/0001171520-25-000195.md) | [0.1](/filings/0001171520-26-000113.md) | [3.0](/filings/0001171520-26-000113.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sotk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.3m | 372,812 | | Added +11,557 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $916.2k | 149,669 | | Added +13,662 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $703.8k | 115,000 | | Added +25,900 | | [M&T Bank Corp](/funds/36270.md) | 2026-06-30 | $489.6k | 80,000 | | Unchanged | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $422.1k | 68,974 | | Added +58,854 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $412.1k | 67,337 | | Added +533 | | [STIFEL FINANCIAL CORP](/funds/720672.md) | 2026-06-30 | $367.2k | 60,000 | | Unchanged | | [BARD ASSOCIATES INC](/funds/1105907.md) | 2026-06-30 | $349.5k | 57,102 | | Added +4,649 | | [Benin Management CORP](/funds/1352871.md) | 2026-06-30 | $264.1k | 43,157 | | Reduced −1,000 | | [Beaumont Financial Advisors, LLC](/funds/1957394.md) | 2026-06-30 | $224.4k | 36,671 | | Unchanged | ## Recent filings [All 726 filings](/companies/sotk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-14 | 12:54 ET | [10-Q](/filings/0001171520-26-000305.md) | Quarterly report, period 2026-08-31 | 0001171520-26-000305 | | 2026-10-14 | 11:10 ET | [8-K](/filings/0001171520-26-000304.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171520-26-000304 | | 2026-08-20 | 20:30 ET | [8-K](/filings/0001171520-26-000231.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171520-26-000231 | | 2026-07-22 | 20:10 ET | [DEF 14A](/filings/0001171520-26-000185.md) | Proxy statement, period 2026-08-20 | 0001171520-26-000185 | | 2026-07-08 | 12:56 ET | [10-Q](/filings/0001171520-26-000167.md) | Quarterly report, period 2026-05-31 | 0001171520-26-000167 | | 2026-07-08 | 11:10 ET | [8-K](/filings/0001171520-26-000166.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171520-26-000166 | | 2026-05-28 | 13:15 ET | [10-K](/filings/0001171520-26-000113.md) | Annual report, period 2026-02-28 | 0001171520-26-000113 | | 2026-05-28 | 11:10 ET | [8-K](/filings/0001171520-26-000111.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171520-26-000111 | | 2026-01-13 | 14:44 ET | [10-Q](/filings/0001171520-26-000004.md) | Quarterly report, period 2025-11-30 | 0001171520-26-000004 | | 2026-01-13 | 12:10 ET | [8-K](/filings/0001171520-26-000002.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171520-26-000002 | ## Latest annual report [Form 10-K for the fiscal year ended Feb 28, 2026](/filings/0001171520-26-000113.md), filed May 28, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 806172 - Tickers: SOTK - Exchange: Nasdaq - SIC code: 3559 Special Industry Machinery, NEC - State of incorporation: NY - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.